{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:37:02Z","timestamp":1760240222331},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.cld.2012.12.006","type":"journal-article","created":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T10:17:09Z","timestamp":1364379429000},"page":"243-253","source":"Crossref","is-referenced-by-count":7,"title":["Cholestatic Liver Disease Overlap Syndromes"],"prefix":"10.1016","volume":"17","author":[{"given":"Marlyn J.","family":"Mayo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cld.2012.12.006_bib1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1478-3231.2004.0924.x","article-title":"Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis","volume":"24","author":"Czaja","year":"2004","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.cld.2012.12.006_bib2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis","volume":"48","author":"O'Brien","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2012.12.006_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2012.12.006_bib4","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1089-3261(03)00092-8","article-title":"Autoimmune overlapping syndromes","volume":"7","author":"Poupon","year":"2003","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.cld.2012.12.006_bib5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.510290444","article-title":"Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression","volume":"29","author":"Degott","year":"1999","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2012.12.006_bib6","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1572-0241.2002.05703.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: an\u00a0evaluation of a modified scoring system","volume":"97","author":"Talwalkar","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2012.12.006_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2012.12.006_bib8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2012.12.006_bib9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2012.12.006_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2012.12.006_bib11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2012.12.006_bib12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/0891693021000064272","article-title":"The hepatitic\/cholestatic \u201coverlap\u201d syndrome: an Italian experience","volume":"35","author":"Muratori","year":"2002","journal-title":"Autoimmunity"},{"issue":"11","key":"10.1016\/j.cld.2012.12.006_bib13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.dld.2010.03.005","article-title":"Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score?","volume":"42","author":"Gatselis","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"6","key":"10.1016\/j.cld.2012.12.006_bib14","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.510230612","article-title":"Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis","volume":"23","author":"Boberg","year":"1996","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2012.12.006_bib15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0168-8278(00)80004-5","article-title":"Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system","volume":"33","author":"Kaya","year":"2000","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2012.12.006_bib16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1600-0641.2000.033004543.x","article-title":"High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis","volume":"33","author":"van Buuren","year":"2000","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2012.12.006_bib17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejim.2008.06.004","article-title":"High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis","volume":"20","author":"Olsson","year":"2009","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.cld.2012.12.006_bib18","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hep.23024","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study","volume":"50","author":"Lewin","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2012.12.006_bib19","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.22073","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging","volume":"47","author":"Abdalian","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2012.12.006_bib20","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2012.12.006_bib21","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/PAS.0b013e3181f7266b","article-title":"IgG4-related disease: a cross-sectional study of 114 cases","volume":"34","author":"Zen","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.cld.2012.12.006_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00535-010-0319-0","article-title":"Small bile duct involvement in IgG4-related sclerosing cholangitis: liver biopsy and cholangiography correlation","volume":"46","author":"Naitoh","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2012.12.006_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ajg.2011.375","article-title":"The spectrum of sclerosing cholangitis and the relevance of IgG4 elevations in routine practice","volume":"107","author":"Alswat","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2012.12.006_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00535-010-0323-4","article-title":"Clinical significance of immunoglobulin G4-associated autoimmune hepatitis","volume":"46","author":"Umemura","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2012.12.006_bib25","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.27435","article-title":"Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease","volume":"62","author":"Khosroshahi","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.cld.2012.12.006_bib26","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.crohns.2012.01.017","article-title":"Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease","volume":"6","author":"van Casteren-Messidoro","year":"2012","journal-title":"J\u00a0Crohns Colitis"},{"issue":"11","key":"10.1016\/j.cld.2012.12.006_bib27","doi-asserted-by":"crossref","first-page":"E149","DOI":"10.1002\/ibd.21880","article-title":"Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate","volume":"17","author":"Subramaniam","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1016\/j.cld.2012.12.006_bib28","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1007\/s10620-011-1748-1","article-title":"Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn's disease: the index case","volume":"56","author":"Goldfeld","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"9","key":"10.1016\/j.cld.2012.12.006_bib29","doi-asserted-by":"crossref","first-page":"524","DOI":"10.5694\/j.1326-5377.2007.tb01396.x","article-title":"Autoimmune hepatitis following infliximab therapy for ankylosing spondylitis","volume":"187","author":"Ozorio","year":"2007","journal-title":"Med J Aust"},{"issue":"2","key":"10.1016\/j.cld.2012.12.006_bib30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/jhep.2002.30902","article-title":"Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid","volume":"35","author":"Joshi","year":"2002","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2012.12.006_bib31","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes","volume":"102","author":"Silveira","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2012.12.006_bib32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","volume":"28","author":"Czaja","year":"1998","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2012.12.006_bib33","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","article-title":"Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals","volume":"29","author":"Lohse","year":"1999","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2012.12.006_bib34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2005.10.017","article-title":"Long term outcome and response to\u00a0therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome","volume":"44","author":"Chazouilleres","year":"2006","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2012.12.006_bib35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00029330-200602010-00013","article-title":"Clinical features of the overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis: retrospective study","volume":"119","author":"Wu","year":"2006","journal-title":"Chin Med J (Engl)"},{"issue":"4\u20135","key":"10.1016\/j.cld.2012.12.006_bib36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.gcb.2010.02.004","article-title":"Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone","volume":"34","author":"Rabahi","year":"2010","journal-title":"Gastroenterol Clin Biol"},{"issue":"2","key":"10.1016\/j.cld.2012.12.006_bib37","first-page":"168","article-title":"Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid","volume":"39","author":"Talwalkar","year":"2005","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"9","key":"10.1016\/j.cld.2012.12.006_bib38","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/00365520310005172","article-title":"Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients","volume":"38","author":"Boberg","year":"2003","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2012.12.006_bib39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","article-title":"Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival","volume":"28","author":"Al-Chalabi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.cld.2012.12.006_bib40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MCG.0b013e318157c614","article-title":"Characteristics and long-term prognosis of the autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"43","author":"Luth","year":"2009","journal-title":"J\u00a0Clin Gastroenterol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326112001523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326112001523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T12:07:55Z","timestamp":1595592475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326112001523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1089326112001523"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2012.12.006","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}